v3.26.1
Acquisitions - Narrative (Details)
3 Months Ended 6 Months Ended
Jul. 08, 2025
USD ($)
Jan. 08, 2025
USD ($)
arrangement
Jun. 30, 2026
USD ($)
Mar. 31, 2026
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Dec. 31, 2025
USD ($)
Aug. 07, 2025
USD ($)
Business Combination [Line Items]                  
Holdback           $ 1,439,000 $ 0    
Business combination, acquisition-related cost, expense     $ 0   $ 4,000,000.0 0 7,200,000    
Call Option                  
Business Combination [Line Items]                  
Stock available for repurchase   $ 10,000,000.0              
Option contract period   5 years              
Redemption requirement, revenue threshold   $ 5,000,000.0              
Akoya Biosciences, Inc.                  
Business Combination [Line Items]                  
Contract with customer, unfavorable terms                 $ 16,700,000
Contract with customer, non-cash revenue recognized       $ 14,000,000.0          
Deferred revenue       7,900,000          
Total fair value of consideration transferred $ 150,973,000                
Cash paid for debt extinguishment $ 82,131,000                
Akoya Biosciences, Inc. | In Process Research and Development                  
Business Combination [Line Items]                  
Indefinite-lived intangible assets:       $ 19,300,000   19,300,000      
Emission                  
Business Combination [Line Items]                  
Total fair value of consideration transferred   16,600,000              
Holdback   $ 1,000,000.0              
Number of contingent consideration arrangements | arrangement   2              
Cash paid for debt extinguishment   $ 6,600,000              
Emission | Earnout 1                  
Business Combination [Line Items]                  
Additional consideration               $ 10,000,000.0  
Cash paid for debt extinguishment         4,200,000   $ 7,900,000    
Emission | Earnout 2                  
Business Combination [Line Items]                  
Additional consideration     $ 49,900,000     $ 49,900,000      
Performance period           5 years      
Cash paid for debt extinguishment         $ 0